Analyst Ratings for Xilio Therapeutics Inc (XLO)
XLO Rating Summary
XLO Price Target Summary
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$2.00 (+277.4%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$2.00 (+277.4%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/6/2025 | Leerink Partners | Daina Graybosch | New Coverage | Outperform (N/A) |
2.00 (N/A) |
0.67 (0.53) |
-20.9% | Details |
| 12/21/2022 | Chardan | Matthew Barcus | New Coverage | Buy (N/A) |
7.00 (N/A) |
1.97 (0.53) |
-73.1% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
